Phenbenzamine
Phenbenzamine (Antergan) is an antihistamine with anticholinergic properties.[1]
![]() | |
| Clinical data | |
|---|---|
| Trade names | Antergan |
| Identifiers | |
IUPAC name
| |
| PubChem CID | |
| ChemSpider |
|
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H22N2 |
| Molar mass | 254.36998 g/mol g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
References
- http://www.britannica.com/EBchecked/topic/455484/phenbenzamine
- L. P. Kyrides and F. B. Zienty, U.S. Patent 2,634,293 (1953).
- Kaye, Irving Allan; Parris, Chester L.; Weiner, Nathan (1953). "A Novel N-Alkylation Reaction". Journal of the American Chemical Society. 75 (3): 744–745. doi:10.1021/ja01099a508. ISSN 0002-7863.
| Benzimidazoles (*) | |
|---|---|
| Diarylmethanes |
|
| Ethylenediamines | |
| Tricyclics | |
| Others |
|
| For topical use | |
Histamine receptor modulators | |
|---|---|
| H1 |
|
| H2 |
|
| H3 |
|
| H4 |
|
See also: Receptor/signaling modulators • Monoamine metabolism modulators • Monoamine reuptake inhibitors | |
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.


